Stignal Injection

About Stignal 500 mcg/ml Injection

Stignal is a 500 mcg/ml injection containing neostigmine methyl sulphate, a medicine from the anti-cholinesterase group. It is given by a healthcare professional in hospital or clinical settings for specific conditions the doctor has assessed.

There are 4 brands of Neostigmine Methyl Sulphate listed in Bangladesh. The lowest listed price is Neos-R 500 mcg/ml Injection at ৳ 8.00 per unit.

What is Stignal 500 mcg/ml Injection?

Stignal 500 mcg/ml injection is a prescription-only medicine that belongs to a group called anti-cholinesterases. It contains neostigmine methyl sulphate and comes as a solution for injection. Because it is given by injection, a doctor or trained healthcare professional administers it and decides the dose and course. It is used in particular situations, such as during surgical anaesthesia and for certain post-operative problems, as well as in the management of myasthenia gravis when oral treatment is not practical. Its action relates to how nerves pass signals to muscles and other organs, and it should only be used under medical supervision.

Uses of Stignal

Stignal 500 mcg/ml injection is used to reverse the effect of a type of muscle-relaxing medicine given during surgery. It is also used to help prevent and treat abdominal bloating and difficulty passing urine after an operation, once a mechanical blockage has been ruled out. In addition, it can be used for control of myasthenia gravis when oral treatment is not practical. Your doctor will decide whether it is suitable for you.

How to use Stignal

Stignal 500 mcg/ml injection is given by a doctor or trained healthcare professional, usually in a hospital or clinic. It may be injected slowly into a vein or given into a muscle or under the skin, depending on why it is being used. You should not try to inject it yourself. The dose and course are chosen by the doctor, who also watches your response and checks for any reactions during and after the injection.

Side effects of Stignal

Stignal 500 mcg/ml injection can cause nausea, vomiting, increased salivation, diarrhoea and abdominal cramps; these may be more noticeable with higher doses. Signs of too much medicine can include more stomach discomfort, increased chest secretions, sweating, involuntary passing of stool or urine, small pupils, unusual eye movements, slow heartbeat, low blood pressure, restlessness, excessive dreaming and muscle weakness. Tell the healthcare team promptly if you notice any of these.

Safety and precautions

Stignal 500 mcg/ml injection is given only under medical supervision. Before use, tell the doctor if you have asthma, a slow heartbeat, a recent heart attack, epilepsy, low blood pressure, Parkinson's disease, increased vagal tone or a peptic ulcer. Do not use it if you are allergic to neostigmine, or if you have peritonitis or a blockage of the intestine or urinary tract. In pregnancy and breastfeeding, it should be used only if the doctor considers it clearly needed, so ask your doctor first. An antidote to some of its effects may be needed, and the doctor will decide on this.

Frequently asked questions

Is Stignal 500 mcg/ml injection safe in pregnancy or breastfeeding?

It should be used in pregnancy only if the doctor decides it is clearly needed; it may cause uterine irritation or premature labour when given into a vein near term. It is not known whether it passes into breast milk. Talk to your doctor before it is used if you are pregnant or breastfeeding.

What is Stignal 500 mcg/ml injection used for and what kind of medicine is it?

It is an anti-cholinesterase medicine containing neostigmine methyl sulphate. It is used to reverse the effect of certain muscle relaxants after surgery, to help with post-operative abdominal bloating and urinary retention once a blockage is excluded, and for control of myasthenia gravis when oral treatment is not practical.

How should Stignal 500 mcg/ml injection be stored?

Store it in a cool, dry place, protected from light. Keep it out of reach of children. If you are given the injection at a clinic or hospital, the healthcare team will store it correctly. Ask your pharmacist if you have questions about storage at home.

Can I give Stignal 500 mcg/ml injection to myself at home?

No. This is a prescription injection that should be given by a doctor or trained healthcare professional, usually in a hospital or clinic. The doctor decides the dose, how it is given and how long it is used. Do not attempt to inject it yourself at home.

Indications

Neostigmine Methyl Sulphate is indicated for-
  • Reversal of nondepolarising neuromuscular blockade for surgical anesthetic procedures
  • The prevention and treatment of post-operative abdominal distention and urinary retention after mechanical obstruction has been excluded.
  • ... Read more
Neostigmine Methyl Sulphate is indicated for-
  • Reversal of nondepolarising neuromuscular blockade for surgical anesthetic procedures
  • The prevention and treatment of post-operative abdominal distention and urinary retention after mechanical obstruction has been excluded.
  • Treatment of the systemic control of Myasthenia Gravis when oral therapy is impractical.

Pharmacology

Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. By interfering with the breakdown of acetylcholine, Neostigmine indirectly stimulates both nicotinic and muscarinic receptors. It does cross the blood-brain barrier but only poorly. Neostigmine binds to the anionic site of cholinesterase. The drug blocks the active site of acetylcholinesterase; so the enzyme can no longer break down the acetylcholine molecules before they reach the postsynaptic membrane receptors. This allows for the threshold to be reached so a new impulse can be triggered in the next neuron. In myasthenia gravis there are too few acetylcholine receptors. So with the acetylcholinesterase blocked, acetylcholine can bind to the few receptors and trigger a muscular contraction.

Dosage & Administration

Reversal of the effects of Non-depolarizing Neurormuscular Blocking Agents: The usual dose is 0.5 to 2 mg given by slow intravenous injection over 60 seconds; repeated as required. Total dose should not exceed 5 mg (in exceptional cases). When Neostigmine is administered intravenously, it is recommended that Atropine Sulphate (0.6-1.2 mg) also be given intravenously using separate syringe.

Prevention of post-operative abdominal distention and urinary retention: 0.25 mg intramuscularly or subcutaneously as soon as possible after operation; repeat every 4 6 hours for 2-3 days.

Treatment of post-operative abdominal distention: 0.5 mg intramuscularly or subcutaneously or as required.

Treatment of urinary retention: 0.5 mg intramuscularly or subcutaneously. If urination does not occur within an hour, the patient should be catheterized. After the patient has voided, or the bladder has been emptied, continue the 0.5 mg injection every 3 hours, for at least 5 injections.

Symptomatic control of Myasthenia Gravis: 0.5 mg intramuscularly or subcutaneously. Subsequent dose should be based on the individual patient's response.

Neonates: 50-250 micrograms (0.1 to 0.5 ml) every 4 hours.

Children: 200-500 micrograms (0.4 ml to 1 ml) as recommended.

Interaction

Anti-arrhythmic Procainamide, Quinidine and possibly Propafenone antagonise effect of Neostigmine. Antibacterials, Aminoglycosides, Clindamycin, Lincomycin and Polymyxins antagonise effect of Neostigmine.

Contraindications

Neostigmine is contraindicated in patients with known hypersensitivity to the drug. It is also contraindicated in patients with peritonitis or mechanical obstruction of the intestinal or urinary tract.

Side Effects

Nausea, vomiting, increased salivation, diarrhoea and abdominal cramps (more marked with high doses). Signs of overdose are increased gastrointestinal discomfort, bronchial secretions and sweating, involuntary defecation and micturition, miosis, nystagmus, bradycardia, hypotension, agitation, excessive dreaming and weakness eventually leading to fasciculation and paralysis.

Pregnancy & Lactation

Pregnancy Category C. There are no adequate or well-controlled studies of Neostigmine in either laboratory animals or in pregnantwomen. It is not known whether Neostigmine can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Neostigmine should be given to a pregnant woman only if clearly needed.

Nonteratogenic Effects: Anticholinesterase drugs may cause uterine irritability and induce premature labor when given intravenously to pregnant women near term.

Nursing Mothers: It is not known whether Neostigmine is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions from Neostigmine in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Asthma, bradycardia, recent myocardial infarction, epilepsy, hypotension, parkinsonism, vagotonia, peptic ulceration. Atropine or other antidote to muscarinic effccts may be necessary (particularly when Neostigmine is given by injection), but it should not be given routinely as it may mask signs of overdose.

Storage Conditions

Store in a cool and dry place, protected from light.

Alternative brands of Neostigmine Methyl Sulphate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.